Product Description: TAS-103 dihydrochloride is a dual inhibitor of DNA topoisomerase I/II, used for cancer research.
Applications: Cancer-programmed cell death
Formula: C20H21Cl2N3O2
References: [1]Padget K, et al. An investigation into the formation of N- [2-(dimethylamino)ethyl]acridine-4-carboxamide (DACA) and 6-[2-(dimethylamino)ethylamino]- 3-hydroxy-7H-indeno[2, 1-C]quinolin-7-one dihydrochloride (TAS-103) stabilised DNA topoisomerase I and II cleavable complexes in human leukaemia cells. Biochem Pharmacol. 2000 Sep 15;60(6):817-21./[2]Shimizu K, et al. Cancer chemotherapy by liposomal 6-[12-(dimethylamino)ethyl]aminol-3-hydroxy-7H-indeno[2,1-clquinolin-7-one dihydrochloride (TAS-103), a novel anti-cancer agent. Biol Pharm Bull. 2002 Oct;25(10):1385-7./[3]Yoshida M, et al. A new mechanism of 6-((2-(dimethylamino)ethyl)amino)-3-hydroxy-7H-indeno(2,1-c)quinolin-7-one dihydrochloride (TAS-103) action discovered by target screening with drug-immobilized affinity beads. Mol Pharmacol. 2008 Mar;73(3):987-94. Epub 2007 Dec 18.
CAS Number: 174634-09-4
Molecular Weight: 406.31
Compound Purity: 98.87
Research Area: Cancer
Solubility: H2O : 5 mg/mL (ultrasonic;warming;heat to 60°C)
Target: Topoisomerase
English
Deutsch
